JPM
JPMorgan Chase & Co.
JPM has the edge over VRTS overall, supported by stronger fundamentals and stronger modeled upside.
VRTS
Virtus Investment Partners, Inc.
VRTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
VRTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
VRTS's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like VRTS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
VRTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.3x | $125 | — |
| Current | 7.7x | $125 | — |
| Cheap | 8.4x | $135 | +8.8% |
| Fair | 11x | $185 | +48% |
| Expensive | 15x | $242 | +94% |
Historical ranges are pointers, not guarantees.
VRTS has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
VRTS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect VRTS's earnings and revenue to decline, with profitability weakening.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over VRTS on earnings, with more consistent year-over-year improvement.
VRTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.84 | +23% |
| Q3 2026 | $16.14 | -17% |
| Q2 2026 | $17.53 | -15% |
| Q1 2026 | $16.97 | +0.8% |
| Q4 2025 | $19.97 | +18% |
| Q3 2025 | $19.47 | +18% |
| Q2 2025 | $20.53 | +38% |
| Q1 2025 | $16.84 | +1.4% |
| Q4 2024 | $16.89 | -4.6% |
VRTS's earnings per share have fallen from their peak: $16.14 over the past year, against $26.01 in late 2021.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over VRTS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over VRTS on profitability, with a higher operating margin.
VRTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $197.6M | -8.7% |
| Q2 2026 | $201.4M | -4.4% |
| Q1 2026 | $199.5M | -8.4% |
| Q4 2025 | $208M | -11% |
| Q3 2025 | $216.4M | -4.7% |
| Q2 2025 | $210.5M | -6.2% |
| Q1 2025 | $217.9M | -1.9% |
| Q4 2024 | $233.5M | +8.8% |
VRTS's revenue has slid since its 2021 peak: $198M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | -4.4 points |
| Q2 2026 | 14% | -7.9 points |
| Q1 2026 | 7.7% | -9 points |
| Q4 2025 | 19% | -2.6 points |
| Q3 2025 | 22% | -2.6 points |
| Q2 2025 | 21% | +1.8 points |
| Q1 2025 | 17% | +2.2 points |
| Q4 2024 | 22% | +3.6 points |
VRTS's operating margin was 17% last quarter, down 4.4 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
VRTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.4M | -30% |
| Q2 2026 | $56.1M | -24% |
| Q1 2026 | $33.5M | +$40.3M |
| Q4 2025 | -$248.4M | -$143.7M |
| Q3 2025 | $106.9M | +55% |
| Q2 2025 | $74.2M | +8.1% |
| Q1 2025 | -$6.8M | +$29.7M |
| Q4 2024 | -$104.7M | -2223% |
VRTS's free cash flow was −$84M over the past year, against $70M the year before. Free cash flow isn't a meaningful measure for financial services companies like VRTS.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over VRTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
VRTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -4K shares |
| 1 year | -1.4% | -93K shares |
| 3 years | -8.2% | -605K shares |
| 5 years | -15% | -1.2M shares |
| Available history | -17% | -1.4M shares |
VRTS has 7M diluted shares, down 1.4% from a year ago, with $40M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2026 | $10.5M |
| Q1 2026 | $10M |
| Q4 2025 | $10M |
| Q3 2025 | — |
| Q2 2025 | $30M |
| Q1 2025 | $20M |
| Q4 2024 | $12.5M |
VRTS spent $40M buying back its own shares over the past year, down 35% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over VRTS on leverage, with a lower net debt burden relative to earnings.
VRTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.7x | Net Cash |
VRTS's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like VRTS.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
VRTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 12.1 | Oversold |
VRTS's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
VRTS PE vs Financial Services Sector
| Metric | VRTS | Sector median | Relative |
|---|---|---|---|
| PE | 7.7x | 13x | 41% below |
| PE % | 12 | 63 | 51 pts below |
VRTS has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over VRTS on trend strength, trading above more of its moving averages.
VRTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $126.0 | 1.1% below |
| 20 week MA | $145.6 | 14% below |
| 50 week MA | $146.4 | 15% below |
| 100 week MA | $165.0 | 24% below |
| 200 week MA | $189.1 | 34% below |
VRTS is in a downtrend: it's below all five of its weekly moving averages, and 34% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over VRTS on returns for 2026, with the stronger performance.
VRTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $122.5 | $214.9 | +75% |
| 2021 | $214.9 | $296.5 | +38% |
| 2022 | $296.5 | $189.9 | -36% |
| 2023 | $189.9 | $241.8 | +27% |
| 2024 | $241.8 | $222.9 | -7.8% |
| 2025 | $222.9 | $166.4 | -25% |
| 2026 YTD | $166.4 | $124.6 | -25% |
VRTS has finished lower in three of the last six years. It's down 25% so far in 2026.